about
Th2 cytokines and asthma. Interleukin-4: its role in the pathogenesis of asthma, and targeting it for asthma treatment with interleukin-4 receptor antagonists.Aspirin-exacerbated respiratory disease: pathophysiological insights and clinical advancesThe alpha-gal story: lessons learned from connecting the dots.Chronic hyperplastic eosinophilic sinusitis as a predictor of aspirin-exacerbated respiratory diseaseExpression of leukotriene C4 synthase and plasminogen activator inhibitor 1 gene promoter polymorphisms in sinusitisBiological effects of leukotriene E4 on eosinophilsRhinovirus infection results in stronger and more persistent genomic dysregulation: Evidence for altered innate immune response in asthmatics at baseline, early in infection, and during convalescenceLack of Efficacy of Symptoms and Medical History in Distinguishing the Degree of Eosinophilia in Nasal Polyps.Effect of probiotic on innate inflammatory response and viral shedding in experimental rhinovirus infection - a randomised controlled trial.Can Genes Control Asthmatic Lung Function Patterns?Immune Responses in Rhinovirus-Induced Asthma Exacerbations.Eosinophils and Mast Cells in Aspirin-Exacerbated Respiratory Disease.Chronic rhinosinusitis phenotypes.Basic science for the clinician: Mechanisms of sublingual and subcutaneous immunotherapy.Altered metabolic profile in patients with IgE to galactose-alpha-1,3-galactose following in vivo food challengeEosinophil production of prostaglandin D2 in patients with aspirin-exacerbated respiratory disease.Factors driving the aspirin exacerbated respiratory disease phenotype.Immune surveillance by rhinovirus-specific circulating CD4+ and CD8+ T lymphocytes.Cysteinyl leukotriene expression in chronic hyperplastic sinusitis-nasal polyposis: importance to eosinophilia and asthma.2. Cytokines and chemokines.5. Genetics of hypersensitivity.Characterization of interleukin-4-stimulated nasal polyp fibroblasts.The role of allergy in chronic rhinosinusitis.Failure of itraconazole to prevent T-helper type 2 cell immune deviation: Implications for chronic rhinosinusitis.Aspirin activation of eosinophils and mast cells: implications in the pathogenesis of aspirin-exacerbated respiratory diseaseComparison of viral load in individuals with and without asthma during infections with rhinovirusT-cell biology in immunotherapy.Prominent role of IFN-γ in patients with aspirin-exacerbated respiratory disease.High titers of IgE antibody to dust mite allergen and risk for wheezing among asthmatic children infected with rhinovirusEtiology of nasal polyps in cystic fibrosis: not a unimodal disease.Autoimmune mechanisms in chronic idiopathic urticaria.A chitosan-based sinus sealant for reduction of adhesion formation in rabbit and sheep models.Evidence for distinct histologic profile of nasal polyps with and without eosinophilia.Characterization of a novel human mast cell line that responds to stem cell factor and expresses functional FcεRIInterleukin-33 in asthma: how big of a role does it play?Interleukin-4 in the Generation of the AERD Phenotype: Implications for Molecular Mechanisms Driving Therapeutic Benefit of Aspirin Desensitization.Leukotriene receptors in rhinitis and sinusitis.Functional analysis of -571 IL-10 promoter polymorphism reveals a repressor element controlled by sp1.Anti-interleukin-4 therapy.Identification of an Sp factor-dependent promoter in GCET, a gene expressed at high levels in germinal center B cells.
P50
Q24791820-D77E8F22-4590-4410-9132-D0BC68A9F064Q26750424-FD9910CC-FE58-45F7-BA2F-F9765176D213Q27023451-3EB3776A-FCD2-4EE2-920C-9DADB47C0B51Q28182005-1286A817-47A9-4B00-A0B1-B6BE1AC232A1Q28201078-FDA6A8F7-C3CA-4845-AA98-9567B148C157Q28238927-64749EFF-B534-480F-BCBC-2EAC3EA371BEQ30252319-B9F92F62-1ED8-4541-8473-2046348614CEQ30252446-3A2114A2-9FF3-4B34-8FF6-01D4A7AC3375Q30252865-3FF30064-9E5F-4091-8213-B52AE4C94FB5Q30275230-187E7E50-AB56-4028-8EC0-F3A4C533289BQ30275562-2CB5041A-3983-467F-9CEE-0E93F8E17F26Q30275780-30218DC7-F68B-44DD-87F4-509AF57F6350Q30275962-CE0442AD-5D38-416B-A62B-74FBAE81E23EQ30276174-AA646CA9-905C-4D2E-8EAE-CCB18F196304Q30276300-87899EB1-5A3E-4A01-8205-5421E965C522Q30276354-1E35367A-513A-4C5B-952A-A0A2E4A645FDQ30300955-65B8CA60-F8AE-4F15-9767-716B0E92B5EAQ30300966-9EEC85B4-2372-42FC-8AD5-3AFE7F5FEAB3Q30310528-66345FC5-9D5B-4E2A-8329-B27F2184FAE3Q30310536-BE43A67C-F90F-408B-9A1F-D68A37B64F75Q30310538-3DA63D0D-F13B-4C19-ACEA-A558D17330FCQ30311131-6DBD9C50-E1E8-485C-94E6-43762DAB1E10Q30312288-C1FD632E-A1CD-473A-A6EC-9F62BCADE04DQ30355164-C8471DB1-4BA0-4957-80EF-EC3DC2F7E067Q30384450-D9C1BD78-00C8-40A6-BF2C-6307F2FFCA0EQ30407613-D8A04A48-B33E-45D3-A752-355ECEC8B457Q30407617-4C8B18DB-590A-49B1-B99D-4343E5B00C2AQ30410446-B1B81763-B4A5-48A5-8821-16FE8C20C441Q30416839-89AB0370-61BC-4B00-BAA8-8BB34C79C5B4Q30417357-39D41ECA-F34C-40CF-B453-9F8F190E78E7Q30417422-6BA272E4-7E71-4449-9674-D71A5E2E4D19Q30418718-8F27121C-A55A-4EEC-89CD-9CA6A1819DE2Q30424781-5E629F6B-354D-4CAC-830F-95A2B326B61EQ30428097-A259662B-50F1-4CDA-8F7A-4526CCF9D052Q30428491-24A04DA8-F104-4263-8909-D1CE9B9792C8Q30428747-88F49B21-5835-4F36-AB50-2CC7723E173FQ30433200-9F0A2271-1421-449E-8016-6797EB717DA4Q30434272-DCE4A286-879A-4618-B78F-3242AD687BCAQ30434751-536C9C8E-402D-46AE-A257-8E80AC824B06Q30434803-FD3F6502-5106-4F31-8DBC-79F738DE9619
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
John W Steinke
@nl
John W. Steinke
@en
John W. Steinke
@es
type
label
John W Steinke
@nl
John W. Steinke
@en
John W. Steinke
@es
altLabel
J Steinke
@en
J W Steinke
@en
J. Steinke
@en
J. W. Steinke
@en
John Steinke
@en
John W Steinke
@en
Steinke JW
@en
Steinke
@en
prefLabel
John W Steinke
@nl
John W. Steinke
@en
John W. Steinke
@es
P106
P1153
7006019453
P31
P496
0000-0003-4571-8473